<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39066191</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>26</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20-21 Registry.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1028</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16071028</ELocationID><Abstract><AbstractText>Long COVID presents with diverse symptoms after COVID-19. Different clusters of symptoms have been reported; however, their persistence beyond 2 years after COVID-19 remains unclear. In this cohort study, we prospectively evaluated individuals with previous severe COVID-19 presenting with long COVID at a two-year follow-up. We characterized the included patients and performed a cluster analysis of symptoms through multiple correspondence analysis and hierarchical clustering. A total of 199 patients with long COVID were included. The median age was 58 years (48-69), 56% were male, and the median follow-up time since the COVID-19 diagnosis was 26 months (IQR: 25, 27). Three symptom clusters were identified: Cluster 1 is characterized by fatigue, myalgia/arthralgia, a low prevalence of symptoms, and a lack of specific symptoms; Cluster 2 is defined by a high prevalence of fatigue, myalgia/arthralgia, and cardiorespiratory symptoms, including palpitations, shortness of breath, cough, and chest pain; and Cluster 3 is demonstrated a high prevalence of ageusia, anosmia, fatigue, and cardiorespiratory symptoms. Our study reinforces the concept of symptom clustering in long COVID, providing evidence that these clusters may persist beyond two years after a COVID-19 diagnosis. This highlights the chronic and debilitating nature of long COVID and the importance of developing strategies to mitigate symptoms in these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arango-Ibanez</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-3601-3279</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Cl&#xed;nicas (CIC), Fundaci&#xf3;n Valle del Lili, Cali 760032, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#xf3;rdoba-Melo</LastName><ForeName>Brayan Daniel</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Centro de Investigaciones Cl&#xed;nicas (CIC), Fundaci&#xf3;n Valle del Lili, Cali 760032, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez Posso</LastName><ForeName>Juliana Mar&#xed;a</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Centro de Investigaciones Cl&#xed;nicas (CIC), Fundaci&#xf3;n Valle del Lili, Cali 760032, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa-Rengifo</LastName><ForeName>Mario Miguel</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Centro de Investigaciones Cl&#xed;nicas (CIC), Fundaci&#xf3;n Valle del Lili, Cali 760032, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera</LastName><ForeName>Cesar J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Departamento de Cardiolog&#xed;a, Centros de Diagn&#xf3;stico y Medicina Avanzada y de Conferencias M&#xe9;dicas y Telemedicina (CEDIMAT), Santo Domingo F3QG+PJ6, Dominican Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintana Da Silva</LastName><ForeName>Miguel Angel</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0009-0001-9322-629X</Identifier><AffiliationInfo><Affiliation>Departamento de Cardiolog&#xed;a, Instituto Cardiovascular Sanatorio MIGONE, Asunci&#xf3;n 1541, Paraguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buitrago</LastName><ForeName>Andr&#xe9;s Felipe</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Departamento de Cardiolog&#xed;a, Fundaci&#xf3;n Santa Fe, Bogota 110111, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coronel Gilio</LastName><ForeName>Mar&#xed;a Lorena</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Departamento de Cardiolog&#xed;a, Instituto de Cardiolog&#xed;a J. F. Cabral, Corrientes 3400, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pow-Chong-Long</LastName><ForeName>Freddy</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Departamento de Cardiolog&#xed;a, Hospital Luis Vernaza, Guayaquil 090306, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Mesa</LastName><ForeName>Juan Esteban</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0002-6635-6224</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Cl&#xed;nicas (CIC), Fundaci&#xf3;n Valle del Lili, Cali 760032, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Ciencias de la Salud, Universidad Icesi, Cali 760031, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Cardiolog&#xed;a, Fundaci&#xf3;n Valle del Lili, Cali 760032, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TQ-2021-1756</GrantID><Agency>Tecnoquimicas S.A.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="Y">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="Y">Myalgia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018771" MajorTopicYN="Y">Arthralgia</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="N">Ageusia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Latin America</Keyword><Keyword MajorTopicYN="N">cluster</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID condition</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>28</Day><Hour>14</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39066191</ArticleId><ArticleId IdType="pmc">PMC11281355</ArticleId><ArticleId IdType="doi">10.3390/v16071028</ArticleId><ArticleId IdType="pii">v16071028</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 10 November 2023)]; Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>Oronsky B., Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A Review of Persistent Post-COVID Syndrome (PPCS) Clin. Rev. Allergy Immunol. 2023;64:66&#x2013;74. doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan N.A., Johnson L. Defining Long COVID: Going Back to the Start. Med. N. Y. 2021;2:501&#x2013;504. doi: 10.1016/j.medj.2021.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.003</ArticleId><ArticleId IdType="pmc">PMC7992371</ArticleId><ArticleId IdType="pubmed">33786465</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC Healthcare Workers.  [(accessed on 20 December 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Pavli A., Theodoridou M., Maltezou H.C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch. Med. Res. 2021;52:575&#x2013;581. doi: 10.1016/j.arcmed.2021.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., McCann K., O&#x2019;Brien C., Savinelli S., Tinago W., Yousif O., Lambert J.S., O&#x2019;Broin C., Feeney E.R., De Barra E., et al. Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms. Open Forum Infect. Dis. 2022;9:ofac060. doi: 10.1093/ofid/ofac060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Q., Joyce E.E., Ebrahimi O.V., Didriksen M., Lovik A., S&#xe6;varsd&#xf3;ttir K.S., Magn&#xfa;sd&#xf3;ttir I., Mikkelsen D.H., Unnarsd&#xf3;ttir A.B., Hauksd&#xf3;ttir A., et al. COVID-19 Illness Severity and 2-Year Prevalence of Physical Symptoms: An Observational Study in Iceland, Sweden, Norway and Denmark. Lancet Reg. Health Eur. 2023;35:100756. doi: 10.1016/j.lanepe.2023.100756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100756</ArticleId><ArticleId IdType="pmc">PMC10730314</ArticleId><ArticleId IdType="pubmed">38115966</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P., Gorelik Y., Gausi B., Bernstine T., Edelstein M. Characterization of Post-COVID Syndromes by Symptom Cluster and Time Period up to 12 Months Post-Infection: A Systematic Review and Meta-Analysis. Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis. 2023;134:1&#x2013;7. doi: 10.1016/j.ijid.2023.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.05.003</ArticleId><ArticleId IdType="pubmed">37150350</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalb A., Armyra E., M&#xe9;ndez-Aranda M., Ugarte-Gil C. COVID-19 in Latin America and the Caribbean: Two Years of the Pandemic. J. Intern. Med. 2022;292:409&#x2013;427. doi: 10.1111/joim.13499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13499</ArticleId><ArticleId IdType="pmc">PMC9115176</ArticleId><ArticleId IdType="pubmed">35411985</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID&#x2014;Household Pulse Survey&#x2014;COVID-19.  [(accessed on 21 December 2023)]; Available online:  https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm.</Citation></Reference><Reference><Citation>Sakhamuri S.M., Jankie S., Pereira L.M.P. Calling on Latin America and the Caribbean Countries to Recognise the Disability from Long COVID. Lancet Reg. Health&#x2014;Am. 2022;15:100362. doi: 10.1016/j.lana.2022.100362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100362</ArticleId><ArticleId IdType="pmc">PMC9412073</ArticleId><ArticleId IdType="pubmed">36043156</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallegos M., Martino P., Razumovskiy A., Portillo N., Calandra M., Caycho-Rodr&#xed;guez T., Cervigni M. S&#xed;ndrome Post COVID-19 en Am&#xe9;rica Latina y el Caribe: Un llamado de atenci&#xf3;n. Rev. M&#xe9;dica Rosario. 2022;88:114&#x2013;118.</Citation></Reference><Reference><Citation>Alvarez-Moreno C.A., Pineda J., Bare&#xf1;o A., Espitia R., Rengifo P. Long COVID-19 in Latin America: Low Prevalence, High Resilience or Low Surveillance and Difficulties Accessing Health Care? Travel Med. Infect. Dis. 2023;51:102492. doi: 10.1016/j.tmaid.2022.102492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2022.102492</ArticleId><ArticleId IdType="pmc">PMC9640373</ArticleId><ArticleId IdType="pubmed">36368518</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Mesa J.E., Galindo-Coral S., Montes M.C., Alarco W., Barisani J.L., Maga&#xf1;a A., Perna E.R., Romero A., Speranza M., Mendoza I., et al. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry. Glob. Heart. 2021;16:14. doi: 10.5334/gh.925.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/gh.925</ArticleId><ArticleId IdType="pmc">PMC7894365</ArticleId><ArticleId IdType="pubmed">33833938</ArticleId></ArticleIdList></Reference><Reference><Citation>Husson F., Josse J., Le S., Mazet J. Package &#x2018;FactoMineR&#x2019;. 2020.  [(accessed on 23 August 2021)].  Available online:  https://cran.rediris.es/web/packages/FactoMineR/FactoMineR.pdf.</Citation></Reference><Reference><Citation>Kim Y., Bae S., Chang H.-H., Kim S.-W. Long COVID Prevalence and Impact on Quality of Life 2 Years after Acute COVID-19. Sci. Rep. 2023;13:11207. doi: 10.1038/s41598-023-36995-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36995-4</ArticleId><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlgren C., Forsberg G., Divanoglou A., &#xd6;stholm Balkhed &#xc5;., Niward K., Berg S., Levi R. Two-Year Follow-up of Patients with Post-COVID-19 Condition in Sweden: A Prospective Cohort Study. Lancet Reg. Health Eur. 2023;28:100595. doi: 10.1016/j.lanepe.2023.100595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100595</ArticleId><ArticleId IdType="pmc">PMC9951394</ArticleId><ArticleId IdType="pubmed">36855599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., Menges D., Anagnostopoulos A., Domenghino A., Aschmann H.E., Frei A., Fehr J.S., Puhan M.A. Recovery and Symptom Trajectories up to Two Years after SARS-CoV-2 Infection: Population Based, Longitudinal Cohort Study. BMJ. 2023;381:e074425. doi: 10.1136/bmj-2022-074425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Bae S., Chang H.-H., Kim S.-W. Characteristics of Long COVID and the Impact of COVID-19 Vaccination on Long COVID 2 Years Following COVID-19 Infection: Prospective Cohort Study. Sci. Rep. 2024;14:854. doi: 10.1038/s41598-023-50024-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-50024-4</ArticleId><ArticleId IdType="pmc">PMC10774352</ArticleId><ArticleId IdType="pubmed">38191556</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Kelly J.D., Lu S., Goldberg S.A., Davidson M.C., Mathur S., Durstenfeld M.S., Spinelli M.A., Hoh R., Tai V., et al. Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement. Open Forum Infect. Dis. 2021;9:ofab640. doi: 10.1093/ofid/ofab640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab640</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Parkin A., Makower S., Greenwood D.C. Post-COVID Syndrome Symptoms, Functional Disability, and Clinical Severity Phenotypes in Hospitalized and Nonhospitalized Individuals: A Cross-sectional Evaluation from a Community COVID Rehabilitation Service. J. Med. Virol. 2022;94:1419&#x2013;1427. doi: 10.1002/jmv.27456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27456</ArticleId><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>Grisanti S.G., Garbarino S., Barisione E., Alo&#xe8; T., Grosso M., Schenone C., Pardini M., Biassoni E., Zaottini F., Picasso R., et al. Neurological Long-COVID in the Outpatient Clinic: Two Subtypes, Two Courses. J. Neurol. Sci. 2022;439:120315. doi: 10.1016/j.jns.2022.120315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120315</ArticleId><ArticleId IdType="pmc">PMC9212262</ArticleId><ArticleId IdType="pubmed">35717880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M.E., Hastie C., Roderick P., Yao G., Alwan N.A. Characteristics and Impact of Long Covid: Findings from an Online Survey. PLoS ONE. 2022;17:e0264331. doi: 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson J.L., Zhou W., Veliz P.T., Smith S. Symptom Clusters in Adults with Post-COVID-19: A Cross-Sectional Survey. Clin. Nurs. Res. 2023;32:1071&#x2013;1080. doi: 10.1177/10547738231191655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738231191655</ArticleId><ArticleId IdType="pubmed">37565330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisiel M.A., Lee S., Malmquist S., Rykatkin O., Holgert S., Janols H., Janson C., Zhou X. Clustering Analysis Identified Three Long COVID Phenotypes and Their Association with General Health Status and Working Ability. J. Clin. Med. 2023;12:3617. doi: 10.3390/jcm12113617.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12113617</ArticleId><ArticleId IdType="pmc">PMC10253616</ArticleId><ArticleId IdType="pubmed">37297812</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T., Yoshimura N., Ishizuka K., Katayama K., Inoue Y., Hirose M., Nakagama Y., Kido Y., Sugimori H., Matsuda T., et al. Five Cluster Classifications of Long COVID and Their Background Factors: A Cross-Sectional Study in Japan. Clin. Exp. Med. 2023;23:3663&#x2013;3670. doi: 10.1007/s10238-023-01057-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01057-6</ArticleId><ArticleId IdType="pmc">PMC10081305</ArticleId><ArticleId IdType="pubmed">37027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Florencio L.L., Navarro-Pardo E., Rodr&#xed;guez-Jim&#xe9;nez J., Torres-Macho J., Pellicer-Valero O.J. Clustering Analysis Reveals Different Profiles Associating Long-Term Post-COVID Symptoms, COVID-19 Symptoms at Hospital Admission and Previous Medical Co-Morbidities in Previously Hospitalized COVID-19 Survivors. Infection. 2023;51:61&#x2013;69. doi: 10.1007/s15010-022-01822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito F., Terai H., Kondo M., Takemura R., Namkoong H., Asakura T., Chubachi S., Masuzawa K., Nakayama S., Suzuki Y., et al. Cluster Analysis of Long COVID in Japan and Association of Its Trajectory of Symptoms and Quality of Life. BMJ Open Respir. Res. 2024;11:e002111. doi: 10.1136/bmjresp-2023-002111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2023-002111</ArticleId><ArticleId IdType="pmc">PMC10895225</ArticleId><ArticleId IdType="pubmed">38395459</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrell G., Puente D., Jacques-Avi&#xf1;&#xf3; C., Carrasco-Ribelles L.A., Viol&#xe1;n C., L&#xf3;pez-Jim&#xe9;nez T., Royano V., Cant&#xf3;n A.M., Medina-Perucha L., Rodr&#xed;guez-Giralt I., et al. Characterisation, Symptom Pattern and Symptom Clusters from a Retrospective Cohort of Long COVID Patients in Primary Care in Catalonia. BMC Infect. Dis. 2024;24:82. doi: 10.1186/s12879-023-08954-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08954-x</ArticleId><ArticleId IdType="pmc">PMC10789045</ArticleId><ArticleId IdType="pubmed">38225587</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Houdt S.C.M., Slurink I.A.L., Mertens G. Long COVID Is Not a Uniform Syndrome: Evidence from Person-Level Symptom Clusters Using Latent Class Analysis. J. Infect. Public Health. 2024;17:321&#x2013;328. doi: 10.1016/j.jiph.2023.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.12.019</ArticleId><ArticleId IdType="pubmed">38183882</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelissen M.E.B., Bloemsma L.D., Vaes A.W., Baalbaki N., Deng Q., Beijers R.J.H.C.G., Noij L.C.E., Houweling L., Bazdar S., Spruit M.A., et al. Fatigue and Symptom-Based Clusters in Post COVID-19 Patients: A Multicentre, Prospective, Observational Cohort Study. J. Transl. Med. 2024;22:191. doi: 10.1186/s12967-024-04979-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-024-04979-1</ArticleId><ArticleId IdType="pmc">PMC10880228</ArticleId><ArticleId IdType="pubmed">38383493</ArticleId></ArticleIdList></Reference><Reference><Citation>Niewolik J., Mikuteit M., Klawitter S., Schr&#xf6;der D., St&#xf6;lting A., Vahldiek K., Heinemann S., M&#xfc;ller F., Behrens G., Klawonn F., et al. Cluster Analysis of Long COVID Symptoms for Deciphering a Syndrome and Its Long-Term Consequence. Immunol. Res. 2024 doi: 10.1007/s12026-024-09465-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-024-09465-w</ArticleId><ArticleId IdType="pmc">PMC11347473</ArticleId><ArticleId IdType="pubmed">38627327</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Shi L., Jiang Z., Zeng N., Mei H., Lu Y., Yang J., Jin F., Ni S., Wu S., et al. The Phenotype and Prediction of Long-Term Physical, Mental and Cognitive COVID-19 Sequelae 20 Months after Recovery, a Community-Based Cohort Study in China. Mol. Psychiatry. 2023;28:1793&#x2013;1801. doi: 10.1038/s41380-023-01951-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-01951-1</ArticleId><ArticleId IdType="pmc">PMC9869317</ArticleId><ArticleId IdType="pubmed">36690792</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Guida F., Polesel J., Marcuzzo A.V., Capriotti V., D&#x2019;Alessandro A., Zanelli E., Marzolino R., Lazzarin C., Antonucci P., et al. Sequelae in Adults at 12 Months after Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) Int. Forum Allergy Rhinol. 2021;11:1685&#x2013;1688. doi: 10.1002/alr.22832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22832</ArticleId><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID Burden and Risk Factors in 10 UK Longitudinal Studies and Electronic Health Records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran B., Le Vu M.N., Le H.T., Nguyen T.H., Boyer L., Fond G., Auquier P., Latkin C.A., Ho R.C.M., Ho C.S.H., et al. Severity and Geographical Disparities of Post-COVID-19 Symptoms among the Vietnamese General Population: A National Evaluation. Sci. Rep. 2023;13:4460. doi: 10.1038/s41598-023-30790-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-30790-x</ArticleId><ArticleId IdType="pmc">PMC10022561</ArticleId><ArticleId IdType="pubmed">36932094</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Thorpe L.E., Simon N.M., de Havenon A., Yaghi S., Sabadia S.B., Yang D., Lewis A., Melmed K., Balcer L.J., et al. Post-Acute Sequelae of COVID-19 Symptom Phenotypes and Therapeutic Strategies: A Prospective, Observational Study. PLoS ONE. 2022;17:e0275274. doi: 10.1371/journal.pone.0275274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275274</ArticleId><ArticleId IdType="pmc">PMC9521913</ArticleId><ArticleId IdType="pubmed">36174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu L., Tebe C., Loste C., Santos J.R., Llad&#xf3;s G., L&#xf3;pez C., Espa&#xf1;a-Cueto S., Toledo R., Font M., Chamorro A., et al. Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: A 2-Year Prospective Observational Cohort Study. Lancet Reg. Health&#x2014;Eur. 2023;33:100724. doi: 10.1016/j.lanepe.2023.100724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100724</ArticleId><ArticleId IdType="pmc">PMC10636281</ArticleId><ArticleId IdType="pubmed">37954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.K.J., Han R., Zhao J.J., Tan N.K.W., Quah E.S.H., Tan C.J.-W., Chan Y.H., Teo N.W.Y., Charn T.C., See A., et al. Prognosis and Persistence of Smell and Taste Dysfunction in Patients with Covid-19: Meta-Analysis with Parametric Cure Modelling of Recovery Curves. BMJ. 2022;378:e069503. doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhou Y., Ma J., Zhang Q., Shao J., Liang S., Yu Y., Li W., Wang C. The Long-Term Health Outcomes, Pathophysiological Mechanisms and Multidisciplinary Management of Long COVID. Signal Transduct. Target. Ther. 2023;8:416. doi: 10.1038/s41392-023-01640-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01640-z</ArticleId><ArticleId IdType="pmc">PMC10618229</ArticleId><ArticleId IdType="pubmed">37907497</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer N., Bart B., Billington C.J., Diem S.J., Ensrud K.E., Kaka A., Klein M., Melzer A.C., Reule S., Shaukat A., et al. COVID-19 Postacute Care Major Organ Damage: A Systematic Review. BMJ Open. 2022;12:e061245. doi: 10.1136/bmjopen-2022-061245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-061245</ArticleId><ArticleId IdType="pmc">PMC9412042</ArticleId><ArticleId IdType="pubmed">36002211</ArticleId></ArticleIdList></Reference><Reference><Citation>Antar A.A.R., Yu T., Demko Z.O., Hu C., Tornheim J.A., Blair P.W., Thomas D.L., Manabe Y.C. Long COVID Brain Fog and Muscle Pain Are Associated with Longer Time to Clearance of SARS-CoV-2 RNA from the Upper Respiratory Tract during Acute Infection. Front. Immunol. 2023;14:1147549. doi: 10.3389/fimmu.2023.1147549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1147549</ArticleId><ArticleId IdType="pmc">PMC10176965</ArticleId><ArticleId IdType="pubmed">37187756</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M., Alcaide P., Asselbergs F.W., Brundel B.J.J.M., Camici G.G., Martins P.d.C., Ferdinandy P., Fontana M., Girao H., Gnecchi M., et al. Long COVID and the Cardiovascular System&#x2014;Elucidating Causes and Cellular Mechanisms in Order to Develop Targeted Diagnostic and Therapeutic Strategies: A Joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc. Res. 2022;119:336&#x2013;356. doi: 10.1093/cvr/cvac115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo A., Bonato M., Cinque P. Smell and Taste Disorders in COVID-19: From Pathogenesis to Clinical Features and Outcomes. Neurosci. Lett. 2021;748:135694. doi: 10.1016/j.neulet.2021.135694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2021.135694</ArticleId><ArticleId IdType="pmc">PMC7883672</ArticleId><ArticleId IdType="pubmed">33600902</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L. Olfactory Dysfunction in COVID-19: Pathology and Long-Term Implications for Brain Health. Trends Mol. Med. 2022;28:781&#x2013;794. doi: 10.1016/j.molmed.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9212891</ArticleId><ArticleId IdType="pubmed">35810128</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated with Post-COVID-19 Condition: A Systematic Review and Meta-Analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A., Reed A.B., Ponzo S., Yassaee A., Aral M., Plans D., Labrique A., Mohan D. Population Risk Factors for Severe Disease and Mortality in COVID-19: A Global Systematic Review and Meta-Analysis. PLoS ONE. 2021;16:e0247461. doi: 10.1371/journal.pone.0247461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247461</ArticleId><ArticleId IdType="pmc">PMC7932512</ArticleId><ArticleId IdType="pubmed">33661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Effect of Covid-19 Vaccination on Long Covid: Systematic Review. BMJ Med. 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>